Genomic and prognostic heterogeneity among RAS/BRAFV600E/TP53 co‐mutated resectable colorectal liver metastases

Hepatic resection is potentially curative for patients with colorectal liver metastases, but the treatment benefit varies. KRAS/NRAS (RAS)/TP53 co‐mutations are associated with a poor prognosis after resection, but there is large variation in patient outcome within the mutation groups, and genetic t...

Full description

Bibliographic Details
Main Authors: Kaja C. G. Berg, Tuva H. Brunsell, Anita Sveen, Sharmini Alagaratnam, Merete Bjørnslett, Merete Hektoen, Kristoffer W. Brudvik, Bård I. Røsok, Bjørn Atle Bjørnbeth, Arild Nesbakken, Ragnhild A. Lothe
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Molecular Oncology
Subjects:
Online Access:https://doi.org/10.1002/1878-0261.12885